000 01273 a2200349 4500
005 20250514190010.0
264 0 _c20040729
008 200407s 0 0 eng d
022 _a0012-3692
024 7 _a10.1378/chest.125.5_suppl.116s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSiegfried, Jill M
245 0 0 _aElevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung.
_h[electronic resource]
260 _bChest
_cMay 2004
300 _a116S-9S p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xchemistry
650 0 4 _aHepatocyte Growth Factor
_xanalysis
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xchemistry
650 0 4 _aMultivariate Analysis
650 0 4 _aNeoplasm Staging
650 0 4 _aPrognosis
650 0 4 _aSurvival Analysis
650 0 4 _aSurvival Rate
700 1 _aLuketich, James D
700 1 _aStabile, Laura P
700 1 _aChristie, Neil
700 1 _aLand, Stephanie R
773 0 _tChest
_gvol. 125
_gno. 5 Suppl
_gp. 116S-9S
856 4 0 _uhttps://doi.org/10.1378/chest.125.5_suppl.116s
_zAvailable from publisher's website
999 _c14845964
_d14845964